Antithrombotic Drug Use in Patients With Ischemic Stroke and Microbleeds

RecruitingOBSERVATIONAL
Enrollment

3,000

Participants

Timeline

Start Date

March 1, 2022

Primary Completion Date

December 1, 2025

Study Completion Date

October 1, 2026

Conditions
Ischemic Stroke
Interventions
DRUG

Antithrombotic drugs

The purpose of our study is to observe the effect of various antithrombotic drugs on the prognosis of ischemic stroke patients with cerebral microbleeds.

Trial Locations (16)

710032

RECRUITING

Department of Neurology, Xijing Hospital, Fourth Military Medical University, Xi'an

RECRUITING

Xi'AN GAOXIN Hospital, Xi'an

719000

RECRUITING

Yulin No.2 Hospital, Yunlin

725000

RECRUITING

Ankang Central Hospital, Ankang

Unknown

RECRUITING

3201 Hospital, Hanzhong

RECRUITING

Yan'an University Affiliated Hospital, Ya'an

RECRUITING

Hanzhong People's Hospital, Hanzhong

RECRUITING

986 Hospital, Xi'an

RECRUITING

Gaoling District Hospital, Xi'an

RECRUITING

Gem Flower Xi'an Changqing Staff Hospital, Xi'an

RECRUITING

Tangdu Hospital, Xi'an

RECRUITING

The First Affiliated Hospital of Xi'an Medical University, Xi'an

RECRUITING

No.215 Hospital of Shaanxi nuclear industry, Xianyang

RECRUITING

The First People's Hospital of Xianyang, Xianyang

RECRUITING

Xian Yang Central Hospital, Xianyang

RECRUITING

Yan'an People's Hospital, Yan’an

All Listed Sponsors
collaborator

Ankang Central Hospital

OTHER

collaborator

Yan'an University Affiliated Hospital

OTHER

lead

Xijing Hospital

OTHER